SCHEMBL31105525

SCHEMBL31105525

CC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(N)=O)C(C)C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ C5AR1 P21730 2/20 0.58
▸ NMBR P28336 2/20 0.56
▸ GRPR P30550 2/20 0.56
▸ CTSL P07711 3/20 0.53
▸ CTSS P25774 3/20 0.53
▸ CTSK P43235 3/20 0.53
▸ CTSH P09668 1/20 0.53
▸ IL23R Q5VWK5 1/20 0.53
▸ NTSR2 O95665 1/20 0.52
▸ NTSR1 P30989 1/20 0.52
▸ SORT1 Q99523 1/20 0.52
▸ CXCR4 P61073 1/20 0.51
▸ MC4R P32245 2/20 0.50
▸ MC5R P33032 2/20 0.50
▸ MC3R P41968 2/20 0.50
▸ MC1R Q01726 2/20 0.50
▸ PTGS1 P23219 1/20 0.49
▸ KISS1R Q969F8 2/20 0.49
▸ TACR1 P25103 1/20 0.49
▸ CAPN1 P07384 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31105546 0.91 CAPN1 (0.58) C5AR1NMBRGRPRCTSLCTSS
SCHEMBL30518116 0.90 NTSR2 (0.58) C5AR1NMBRGRPRCTSLCTSS
SCHEMBL31475697 0.87 NMBR (0.60) C5AR1NMBRGRPRCTSLCTSS
SCHEMBL30608996 0.86 CAPN1 (0.58) C5AR1NMBRGRPRCTSLCTSS
SCHEMBL29945131 0.85 NMBR (0.62) C5AR1NMBRGRPRCTSLCTSS
SCHEMBL31725226 0.84 NMBR (0.60) C5AR1NMBRGRPRCTSLCTSS
SCHEMBL31105542 0.84 NTSR2 (0.64) C5AR1NMBRGRPRCTSLCTSS
SCHEMBL31105647 0.84 C5AR1 (0.60) C5AR1NMBRGRPRCTSLCTSS
SCHEMBL21386022 0.84 C5AR1 (0.65) C5AR1NMBRGRPRCTSLCTSS
SCHEMBL16455231 0.84 C5AR1 (0.68) C5AR1CTSLCTSSCTSKCTSH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078144-A1 ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF WINKEY TECH USA INC (US) 2026-03-19 — — US claimed
WO-2024217503-A1 ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF 深圳市维琪科技股份有限公司 2024-10-24 — — WO claimed
US-20260078144-A1 ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF WINKEY TECH USA INC (US) 2026-03-19 — — US disclosed
WO-2024217503-A1 ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF 深圳市维琪科技股份有限公司 2024-10-24 — — WO disclosed
CN-117343140-B Active peptide, composition and use thereof 深圳市维琪科技股份有限公司 2024-09-20 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078144-A1 ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF ARGLU1, ARG1, POT1 C5AR1 1713/4885NMBR 2716/4885GRPR 450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback